No Data
No Data
Earnings Call Summary | ImmuCell(ICCC.US) Q1 2024 Earnings Conference
The following is a summary of the ImmuCell Corporation (ICCC) Q1 2024 Earnings Call Transcript:Financial Performance:ImmuCell's Q1 2024 product sales have seen a significant jump of 111% compared to Q
ImmuCell Corporation (ICCC) Q1 2024 Earnings Call Transcript
ImmuCell Corporation (ICCC) Q1 2024 Earnings Call Transcript
Express News | ImmuCell Reports $7.3M In Product Sales For Quarter Ended March 31, 2024
ImmuCell | 10-Q: Quarterly report
Express News | ImmuCell Corporation Q1 Basic EPS USD -0.06
ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2024
ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, today announced its unaudited financial results for the quarter ended March 31, 2024.
No Data